210 related articles for article (PubMed ID: 23626767)
1. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression.
Orme RP; Bhangal MS; Fricker RA
PLoS One; 2013; 8(4):e62040. PubMed ID: 23626767
[TBL] [Abstract][Full Text] [Related]
2. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
Fonseca CP; Gama S; Saavedra A; Baltazar G
Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
[TBL] [Abstract][Full Text] [Related]
3. Induction of glial cell line-derived neurotrophic factor by the squamosamide derivative FLZ in astroglia has neuroprotective effects on dopaminergic neurons.
Bao XQ; Wang L; Yang HY; Hou LY; Wang QS; Zhang D
Brain Res Bull; 2020 Jan; 154():32-42. PubMed ID: 31669104
[TBL] [Abstract][Full Text] [Related]
4. Effects of Forskolin on Trefoil factor 1 expression in cultured ventral mesencephalic dopaminergic neurons.
Jensen P; Ducray AD; Widmer HR; Meyer M
Neuroscience; 2015 Dec; 310():699-708. PubMed ID: 26459015
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons.
Pertile RAN; Cui X; Hammond L; Eyles DW
FASEB J; 2018 Feb; 32(2):819-828. PubMed ID: 29018141
[TBL] [Abstract][Full Text] [Related]
6. Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways.
Engele J; Franke B
Cell Tissue Res; 1996 Nov; 286(2):235-40. PubMed ID: 8854892
[TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H
Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161
[TBL] [Abstract][Full Text] [Related]
8. GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones.
Campos FL; Cristovão AC; Rocha SM; Fonseca CP; Baltazar G
J Neuroendocrinol; 2012 Nov; 24(11):1386-97. PubMed ID: 22672424
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
Wood TK; McDermott KW; Sullivan AM
J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons.
Widmer HR; Schaller B; Meyer M; Seiler RW
Exp Neurol; 2000 Jul; 164(1):71-81. PubMed ID: 10877917
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson's disease models.
Ucar B; Humpel C
Brain Res Bull; 2019 Jul; 149():86-95. PubMed ID: 31004735
[TBL] [Abstract][Full Text] [Related]
12. Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.
Drinkut A; Tillack K; Meka DP; Schulz JB; Kügler S; Kramer ER
Cell Death Dis; 2016 Sep; 7(9):e2359. PubMed ID: 27607574
[TBL] [Abstract][Full Text] [Related]
13. GDNF signaling in embryonic midbrain neurons in vitro.
Consales C; Volpicelli F; Greco D; Leone L; Colucci-D'Amato L; Perrone-Capano C; di Porzio U
Brain Res; 2007 Jul; 1159():28-39. PubMed ID: 17574220
[TBL] [Abstract][Full Text] [Related]
14. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.
Granholm AC; Reyland M; Albeck D; Sanders L; Gerhardt G; Hoernig G; Shen L; Westphal H; Hoffer B
J Neurosci; 2000 May; 20(9):3182-90. PubMed ID: 10777782
[TBL] [Abstract][Full Text] [Related]
16. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.
af Bjerkén S; Boger HA; Nelson M; Hoffer BJ; Granholm AC; Strömberg I
Brain Res; 2007 Feb; 1133(1):10-9. PubMed ID: 17184739
[TBL] [Abstract][Full Text] [Related]
17. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
Sun X; Xiong Z; Zhang Y; Meng Y; Xu G; Xia Z; Li J; Zhang R; Ke Z; Xia Z; Hu Y
J Neurochem; 2012 Mar; 120(6):1072-83. PubMed ID: 22192054
[TBL] [Abstract][Full Text] [Related]
18. Changing responsiveness of developing midbrain dopaminergic neurons for extracellular growth factors.
Engele J
J Neurosci Res; 1998 Feb; 51(4):508-16. PubMed ID: 9514204
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons.
Pong K; Xu RY; Beck KD; Zhang TJ; Louis JC
J Neurochem; 1997 Sep; 69(3):986-94. PubMed ID: 9282920
[TBL] [Abstract][Full Text] [Related]
20. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures.
Jaumotte JD; Zigmond MJ
J Neurosci Res; 2014 Nov; 92(11):1425-33. PubMed ID: 24916473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
